Participants
RECRUITMENT, GESTATIONAL DIABETES, PREGNANCY COMPLICATIONS, HIGH-RISK PREGNANCY, PRETERM LABOR, PREECLAMPSIA
Recruitment was carried out between February 23, 2022 and March 23, 2022. Women greater than 18-years-old, 20–35 weeks pregnant (based on last menstrual period), living with HIV and currently prescribed antiretroviral therapy (ART) were included. Women were excluded if they were having a high-risk pregnancy for reasons other than HIV status (e.g., pregnancy complications, preeclampsia, gestational diabetes, preterm labor), already participating in another ART adherence-related study, unable to understand the consent process, or planning to relocate out of the greater Kisumu area within 12 months.Clinic staff conducted an initial screening of all pregnant WLWH being seen at the clinic. Interested women were then referred to our on-site research coordinators who met individually in a private room with women to verify their eligibility and interest to participate in the trial; women who remained willing and able to participate provided written informed consent.